Opportunities in Life Science Molecules: Global Partnership Summit
An Executive Summit designed to assist participants become global players in the growing Life science industry through knowledge and business facilitation
With barely a month to go for the next annual edition of Frost & Sullivan's Global Partnership Summit on the Opportunities in life science Molecules, the response from both Indian and International companies has been extremely positive and encouraging if not better than what was received last year. A 5-star beach resort set in a scenic location such as Goa (India) provides just the right ambience for a focused summit addressing strategic issues concerning the way the global life science companies do business with Indian companies and vice versa.
While last year saw the participation of 15 International companies and more than double the number of Indian firms, the confirmations this year include delegates from the top 50 innovator pharma majors, biotech companies and large fine chemical companies, from the US, Europe, Japan and Latin America; and they would be interacting with corporate and research heads from the large Indian life science industry. With such an august gathering of decision makers who have the potential to change the way the life science industry does business, this summit does prove to be an ideal platform for knowledge sharing with ample opportunity for business networking with Indian companies.
The entire agenda for the 2 day summit has been framed after thorough interaction with industry participants. Presentations cover key and strategic issues, and are not limited to the following:
- Contract Research & Manufacturing Services: Opportunities from a Partner/Customer Perspective
- An industry imperative on Drug Discovery Outsourcing and how to expand capacity
- Scope for greater synergies and alliances in bio-specialties
- Current IP Scenario in India and how to secure value by finding innovation in unlikely places
- Challenges in Outsourcing to India and China, with a detailed comparative analysis
- Growing cross-border partnerships with the Japanese and Latin American life science companies
- Key success stories in outsourcing, from a global pharma company's perspective
Besides presentations and keynote speeches by industry stalwarts, the summit also includes interactive modules such as:
- A focused panel discussion titled, "Acquisitions versus Licensing versus Alliances - What works best under different scenarios?" - panel members include thought leaders from Indian and International pharma companies with years of experience.
- An interactive case study cum growth workshop in biologics and bio-specialties, aimed at knowledge exchange, decision making, building successful alliances, etc
With the support of 2 national and 6 international media partners, this high profile summit being held at Goa (India), provides participating delegates a great opportunity to listen to current issues being addressed by global leaders, a chance to personally interact with key decision makers from the Indian and International life science community, opportunity to understand key strategies that will help improve the way companies do business with India, an above all an ideal platform to talk shop and strike business deals.
For registration enquiries and other details regarding the event, please use the 'Contact' button below.
Organizations
Related link
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Ranbaxy to Bring in Daiichi Sankyo as Majority Partner
Tecan and the Monash Antibody Technologies Facility join forces to produce monoclonal antibody production facility - New state-of-the-art monoclonal antibody production system capable of producing thousands of novel antibodies every year for researchers around the world
TGen and Affymetrix Partner to Use GeneChip(R) DNA Analysis Products in Major Collaborative Programs - Genotyping Technology that Leverages an Innovative Whole-Genome SNP Assay Is Available to Commercial and Academic Research Partners and Future Collaborators

How skin cells protect themselves against stress - Cell biologists have developed a new method for measuring how mechanical forces in cells are processed

Who am I? How cells find their identity
Discovery of the adherence mechanism of red algae to the rock
Plastics chemical retards growth, function of adult reproductive cells
Biotest AG: First time Revenue and EBIT contribution by Biotherapeutics Segment - Continuing difficult Plasma Protein Product Environment
Novasep to sell its Bahamian plant
Alligator Bioscience enters into research and option agreement with BioInvent to jointly develop Antibody-based therapeutics
